Bright Peak Therapeutics Announces the Appointment of Cancer Immunotherapy Leader Jon Wigginton, M.D., as President of Research and Development

SAN DIEGO and BASEL, Switzerland, Aug. 22 (Korea Bizwire) — Bright Peak Therapeutics, a biotechnology company developing next-generation precision immunotherapies to treat cancer and autoimmune disease, today announced the appointment of Jon Wigginton, M.D., as its President of Research and Development. “With a lifelong dedication to improving the lives of patients with cancer, Dr. Wigginton [...]